Sarepta shares get outperform rating on Elevidys approval By Investing.com
On Thursday, Sarepta Therapeutics (NASDAQ:) shares obtained a optimistic outlook from Raymond James as protection was resumed with an Outperform ...
On Thursday, Sarepta Therapeutics (NASDAQ:) shares obtained a optimistic outlook from Raymond James as protection was resumed with an Outperform ...
Investing.com - Sarepta Therapeutics (NASDAQ:), a pioneer in precision genetic drugs for uncommon illnesses, surged in Thursday's after-hours offers after ...
Copyright © 2023 expertrefi.org.
expertrefi.org is not responsible for the content of external sites.
Copyright © 2023 expertrefi.org.
expertrefi.org is not responsible for the content of external sites.